药物遗传学，伦理问题：对纳菲尔德生物伦理委员会报告的综述
Pharmacogenetics, ethical issues: review of the Nuffield Council on Bioethics Report.
作者信息
Corrigan O P
机构信息
Centre for Family Research and Cambridge Genetics Knowledge Park, Faculty of Social and Political Sciences, University of Cambridge, Free School Lane, Cambridge, B2 3RF, UK.
出版信息
J Med Ethics. 2005 Mar;31(3):144-8. doi: 10.1136/jme.2004.007229.
Abstract
In September this year the Nuffield Council on Bioethics held a meeting to disclose and discuss the main findings of their newly published report on the ethical issues associated with developments in pharmacogenetics research. The basics of pharmacogenetics science is briefly outlined, and then the extent to which the report was successful in addressing (or at least highlighting) the attendant social, ethical, and policy implications of pharmacogenetics research is evaluated.
摘要
今年9月，纳菲尔德生物伦理委员会召开了一次会议，以披露并讨论其新发表的关于药物遗传学研究进展相关伦理问题报告的主要研究结果。文中简要概述了药物遗传学的科学基础，随后评估了该报告在处理（或至少突出）药物遗传学研究随之而来的社会、伦理和政策影响方面的成功程度。
相似文献
1
Pharmacogenetics, ethical issues: review of the Nuffield Council on Bioethics Report.药物遗传学，伦理问题：对纳菲尔德生物伦理委员会报告的综述
J Med Ethics. 2005 Mar;31(3):144-8. doi: 10.1136/jme.2004.007229.
2
Nuffield Council on Bioethics consultation.
Pharmacogenomics. 2003 Jan;4(1):91-5. doi: 10.1517/phgs.4.1.91.22585.
3
4
Pharmacogenetics: ethical issues and policy options.药物遗传学：伦理问题与政策选择。
Kennedy Inst Ethics J. 2002 Mar;12(1):1-15. doi: 10.1353/ken.2002.0001.
5
Context, ethics and pharmacogenetics.背景、伦理与药物遗传学
Stud Hist Philos Biol Biomed Sci. 2006 Sep;37(3):566-82. doi: 10.1016/j.shpsc.2006.06.003. Epub 2006 Aug 23.
6
Informed consent in the context of pharmacogenomic research: ethical considerations.在药物基因组学研究背景下的知情同意：伦理考量。
Pharmacogenomics J. 2011 Jun;11(3):155-61. doi: 10.1038/tpj.2011.11. Epub 2011 Mar 29.
7
Pharmacogenetics--legal, ethical and regulatory considerations.药物遗传学——法律、伦理及监管方面的考量
Pharmacogenomics. 2001 Nov;2(4):317-27. doi: 10.1517/14622416.2.4.317.
8
Who should fund and control the direction of human behavior genetics? Review of Nuffield Council on Bioethics 2002 report, genetics and human behaviour: the ethical context.谁应该为人类行为遗传学提供资金并控制其研究方向？对英国纳菲尔德生物伦理委员会2002年报告《遗传学与人类行为：伦理背景》的评论。
Genes Brain Behav. 2003 Dec;2(6):321-6; discussion 330-1. doi: 10.1046/j.1601-1848.2003.00032.x.
9
Using pharmacogenetics and pharmacogenomics in the treatment of psychiatric disorders: some ethical and economic considerations.在精神疾病治疗中应用药物遗传学和药物基因组学：一些伦理和经济考量
J Mol Med (Berl). 2004 Jan;82(1):21-30. doi: 10.1007/s00109-003-0496-x. Epub 2003 Nov 4.
10
Ethics in qualitative health research.定性健康研究中的伦理问题。
Ann R Coll Physicians Surg Can. 2002 Dec;35(8 Suppl.):563-6.
引用本文的文献
1
Pharmacogenomics in clinical trials: an overview.临床试验中的药物基因组学：概述
Front Pharmacol. 2023 Oct 20;14:1247088. doi: 10.3389/fphar.2023.1247088. eCollection 2023.
2
Perceptions of students in health and molecular life sciences regarding pharmacogenomics and personalized medicine.健康与分子生命科学专业学生对药物基因组学和个性化医学的认知。
Hum Genomics. 2018 Nov 14;12(1):50. doi: 10.1186/s40246-018-0182-2.
3
Cost-Effectiveness of Pharmacogenomic and Pharmacogenetic Test-Guided Personalized Therapies: A Systematic Review of the Approved Active Substances for Personalized Medicine in Germany.药物基因组学和药物遗传学检测指导的个性化疗法的成本效益：对德国批准的个性化医疗活性物质的系统评价。
Adv Ther. 2016 Sep;33(9):1461-80. doi: 10.1007/s12325-016-0376-8. Epub 2016 Jul 12.
4
Re-focusing the ethical discourse on personalized medicine: a qualitative interview study with stakeholders in the German healthcare system.重新聚焦个性化医学的伦理讨论：德国医疗保健系统利益相关者的定性访谈研究。
BMC Med Ethics. 2013 May 24;14:20. doi: 10.1186/1472-6939-14-20.
5
Pharmacogenomics of breast cancer therapy: an update.乳腺癌治疗的药物基因组学：最新进展。
Pharmacol Ther. 2013 Jul;139(1):1-11. doi: 10.1016/j.pharmthera.2013.03.001. Epub 2013 Mar 13.
6
Introduction to the special section on genomics.基因组学专题介绍。
Child Dev. 2013 Jan-Feb;84(1):6-16. doi: 10.1111/cdev.12045.
7
Ethical concerns related to developing pharmacogenomic treatment strategies for addiction.与开发针对成瘾的药物基因组治疗策略相关的伦理问题。
Addict Sci Clin Pract. 2011 Jul;6(1):32-43.
8
Ethical considerations for pharmacogenomic testing in pediatric clinical care and research.儿科临床照护和研究中进行药物基因组学检测的伦理考量。
Pharmacogenomics. 2011 Jun;12(6):889-95. doi: 10.2217/pgs.10.216.
9
Response to written feedback of clinical data within a longitudinal study: a qualitative study exploring the ethical implications.对纵向研究中临床数据书面反馈的回应：一项探索伦理影响的定性研究
BMC Med Res Methodol. 2011 Jan 27;11:10. doi: 10.1186/1471-2288-11-10.
10
Personalized medicine in psychiatry: ethical challenges and opportunities.精神病学中的个性化医疗：伦理挑战与机遇。
Dialogues Clin Neurosci. 2009;11(4):427-34. doi: 10.31887/DCNS.2009.11.4/kevers.
本文引用的文献
1
Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients.药物不良反应作为入院原因：对18820例患者的前瞻性分析。
BMJ. 2004 Jul 3;329(7456):15-9. doi: 10.1136/bmj.329.7456.15.
2
Use of pharmacogenetics and clinical factors to predict the maintenance dose of warfarin.利用药物遗传学和临床因素预测华法林维持剂量
Thromb Haemost. 2004 Jan;91(1):87-94. doi: 10.1160/TH03-06-0379.
3
Rhetoric and hype: where's the 'ethics' in pharmacogenomics?花言巧语与大肆炒作：药物基因组学中的“伦理道德”何在？
Am J Pharmacogenomics. 2003;3(6):375-83. doi: 10.2165/00129785-200303060-00004.
4
The drugs don't work: expectations and the shaping of pharmacogenetics.药物不起作用：期望与药物遗传学的形成
Soc Stud Sci. 2003 Jun;33(3):327-64. doi: 10.1177/03063127030333002.
5
Ethical, social and legal implications of pharmacogenomics: a critical review.药物基因组学的伦理、社会及法律影响：批判性综述
Community Genet. 2001;4(4):204-14. doi: 10.1159/000064194.
6
Dyspepsia management in the millennium: to test and treat or not?千禧年的消化不良管理：检测与治疗与否？
Gut. 2003 Jan;52(1):10-1. doi: 10.1136/gut.52.1.10.
7
Emerging ethical issues in pharmacogenomics: from research to clinical practice.药物基因组学中出现的伦理问题：从研究到临床实践
Am J Pharmacogenomics. 2002;2(4):273-81. doi: 10.2165/00129785-200202040-00007.
8
The ethics of access to online genetic databases: private or public?获取在线基因数据库的伦理问题：私有还是公有？
Am J Pharmacogenomics. 2002;2(3):207-12. doi: 10.2165/00129785-200202030-00006.
9
Pharmacogenetics: ethical issues and policy options.药物遗传学：伦理问题与政策选择。
Kennedy Inst Ethics J. 2002 Mar;12(1):1-15. doi: 10.1353/ken.2002.0001.
10
Genome-based pharmacogenetics and the pharmaceutical industry.
Nat Rev Drug Discov. 2002 Jul;1(7):541-9. doi: 10.1038/nrd840.
Zotero 插件